Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
University of Oslo
Oslo, NoruegaUniversity of Oslo-ko ikertzaileekin lankidetzan egindako argitalpenak (46)
2024
-
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma
Haematologica
-
Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI)
Pediatric Research
-
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review
European Journal of Neurology, Vol. 31, Núm. 6
-
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
The Lancet Oncology, Vol. 25, Núm. 5, pp. e205-e216
-
Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
Haematologica, Vol. 109, Núm. 7, pp. 2239-2249
-
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S
European Journal of Neurology
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1655-1675
-
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2
Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1676-1695
-
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies
Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393
-
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia, Vol. 23, Núm. 1, pp. e59-e70
-
Comparison between the difficulty of laparoscopic limited liver resections of tumors located in segment 7 versus segment 8: An international multicenter propensity-score matched study
Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 30, Núm. 2, pp. 177-191
-
Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
EJHAEM, Vol. 4, Núm. 4, pp. 1117-1131
-
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Leukemia, Vol. 37, Núm. 6, pp. 1175-1185
-
Neurobiology of eating behavior, nutrition, and health
Journal of Internal Medicine, Vol. 294, Núm. 5, pp. 582-604
-
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216